Revak S D, Rice C L, Schraufstätter I U, Halsey W A, Bohl B P, Clancy R M, Cochrane C G
Department of Immunology, Scripps Clinic and Research Foundation, La Jolla, CA 92037, USA.
J Clin Invest. 1985 Sep;76(3):1182-92. doi: 10.1172/JCI112074.
Inflammatory pulmonary injury was induced in Macaca mulatta rhesus monkeys by the intrabronchial instillation of the formylated peptide norleu-leu-phe (FNLP) or phorbol myristate acetate (PMA). Indicators of pulmonary injury included an increase in mean protein content of bronchoalveolar lavage (BAL) fluid from 0.51 mg/ml in untreated animals to 3.74 mg/ml and 6.64 mg/ml in FNLP- and PMA-treated animals, respectively, the appearance of a diffuse pulmonary infiltrate in chest roentgenograms, and histologic evidence of a predominantly neutrophilic leukocytic infiltration. Concomitant with the appearance of pulmonary injury was the generation of proteases and oxidants in the BAL fluids. Neutrophil elastase, bound to alpha 1-protease inhibitor (alpha 1-PI), was found to increase from 0.47 micrograms/ml in untreated monkeys to 0.99 micrograms/ml in FNLP-treated animals and 1.23 micrograms/ml in monkeys receiving PMA. Radioiodinated human prekallikrein, instilled for 2 min into the inflammatory site and retrieved by lavaging, was found to have undergone proteolytic cleavage; this cleavage was not consistently inhibitable with the inclusion of antibody to elastase. BAL fluids were shown to contain an amidolytic activity when tested on the synthetic substrate H-D-pro-phe-arg-pNA. This activity was partially inhibitable with known inhibitors of active Hageman factor and kallikrein. beta-Glucuronidase levels in the BAL fluids increased from 0.85 U/ml to 4.36 U/ml and 8.25 U/ml in FNLP- and PMA-treated animals, respectively. Myeloperoxidase (MPO) levels also increased from 1.37 OD U/ml X min to 16.59 and 30.47 OD U/ml X min in the same groups of animals. Oxidant generation was also assessed in several different ways. The specific activity of the oxidant-sensitive inhibitor alpha 1-PI recovered in the BAL fluid decreased from 0.80 in control samples to 0.57 and 0.65 in FNLP- and PMA-treated animals. That this inactivation was due to oxidant injury of the molecule was confirmed by the return to full activity of four out of five BAL samples after their incubation with the reducing agent dithiothreitol in the presence of methionine sulfoxide peptide reductase. The specific activity of catalase in the BAL fluids of animals given 3-amino, 1,2,4 triazole (AT) 1 h before lavaging showed drops from 0.97 in untreated monkeys to 0.04 in FNLP-treated and 0.49 in PMA-treated monkeys. MPO levels also fell in the AT-treated injured animals from 16.59 to 0.85 delta OD/min X ml in FNLP animals in the absence and presence of AT, and 30.47 to 0.60 delta OD/min X ml in PMA-treated animals. Inhibition of MPO by AT was shown in vitro to be H2O2 dependent. Total glutathione levels in the BAL fluids did not change appreciably after FNLP or PMA treatment. These studies present substantial evidence of the generation of both proteases and oxidants during the establishment of acute pulmonary inflammatory injury in an experimental primate model.
通过支气管内滴注甲酰化肽去甲亮氨酸 - 亮氨酸 - 苯丙氨酸(FNLP)或佛波酯(PMA),在恒河猴中诱导炎症性肺损伤。肺损伤的指标包括支气管肺泡灌洗(BAL)液的平均蛋白质含量增加,未治疗动物的BAL液平均蛋白质含量为0.51mg/ml,而FNLP和PMA治疗的动物分别增加到3.74mg/ml和6.64mg/ml;胸部X线片出现弥漫性肺浸润;以及主要为中性粒细胞浸润的组织学证据。伴随肺损伤出现的是BAL液中蛋白酶和氧化剂的产生。与α1 - 蛋白酶抑制剂(α1 - PI)结合的中性粒细胞弹性蛋白酶,在未治疗的猴子中为0.47μg/ml,在FNLP治疗的动物中增加到0.99μg/ml,在接受PMA的猴子中增加到1.23μg/ml。将放射性碘化的人前激肽释放酶滴注到炎症部位2分钟,然后通过灌洗回收,发现其发生了蛋白水解裂解;这种裂解不能通过加入弹性蛋白酶抗体而始终得到抑制。当用合成底物H - D - 脯氨酸 - 苯丙氨酸 - 精氨酸 - 对硝基苯胺进行测试时,BAL液显示出酰胺水解活性。这种活性可被已知的活性Hageman因子和激肽释放酶抑制剂部分抑制。FNLP和PMA治疗的动物的BAL液中β - 葡萄糖醛酸酶水平分别从0.85U/ml增加到4.36U/ml和8.25U/ml。同一组动物的髓过氧化物酶(MPO)水平也从1.37OD U/ml×min增加到16.59和30.47OD U/ml×min。还通过几种不同方法评估了氧化剂的产生。在BAL液中回收的对氧化剂敏感的抑制剂α1 - PI的比活性,在对照样品中为0.80,在FNLP和PMA治疗的动物中分别降至0.57和0.65。在甲硫氨酸亚砜肽还原酶存在下,用还原剂二硫苏糖醇孵育后,五个BAL样品中有四个恢复到完全活性,证实这种失活是由于该分子的氧化损伤。在灌洗前给予3 - 氨基 - 1,2,4 - 三唑(AT)1小时的动物的BAL液中,过氧化氢酶的比活性从未治疗猴子的0.97降至FNLP治疗猴子的0.04和PMA治疗猴子的0.49。在AT处理的损伤动物中,MPO水平在不存在和存在AT时,在FNLP动物中从16.59降至0.85ΔOD/min×ml,在PMA治疗的动物中从30.47降至0.60ΔOD/min×ml。体外研究表明,AT对MPO的抑制作用依赖于H2O2。FNLP或PMA治疗后,BAL液中的总谷胱甘肽水平没有明显变化。这些研究提供了大量证据,证明在实验性灵长类动物模型中,急性肺炎症性损伤形成过程中会产生蛋白酶和氧化剂。